Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if an investigational treatment is effective compared with placebo in the treatment of adults and children with adenoviral conjunctivitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02998554
Study type Interventional
Source Takeda
Contact
Status Terminated
Phase Phase 3
Start date March 28, 2017
Completion date May 16, 2019

See also
  Status Clinical Trial Phase
Completed NCT01532336 - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Phase 2
Terminated NCT02998541 - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Phase 3
Completed NCT02472223 - Reducing Adenoviral Patient Infected Days N/A
Terminated NCT00901693 - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis Phase 2
Withdrawn NCT03009799 - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Phase 2
Active, not recruiting NCT03856645 - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis Phase 2
Completed NCT00266734 - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears N/A
Recruiting NCT03749317 - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis Phase 2